Where can I buy imported original research sparsentan/sparsentan?
Sparsentan is a novel medication that reduces proteinuria in adults with primary immunoglobulin A nephropathy who are at risk for rapid disease progression. The drug works through a dual mechanism. On the one hand, it selectively antagonizes angiotensinII receptors, and on the other hand, it inhibits the synthesis of endogenous epinephrine, thereby effectively lowering blood pressure and reducing the burden on the kidneys. This dual mechanism allows sparsentane not only to control blood pressure during treatment, but also to protect kidney tissue and slow down disease progression.
At present, Sparsentan has gained certain recognition in the international market, especially in Europe, the United States and other countries, and has been approved by relevant regulatory agencies. However, in the Chinese market, the original drug of sparsentan has not yet been officially launched, so its price and availability are still unclear. This makes it difficult for many patients who need the drug to take it.
As for the specifications of Sparsentan, the current European version mainly has two specifications: 200mg and 400mg, with 30 tablets per bottle, and the overall cost is relatively high. Since drugs are released in overseas markets for a short period of time, their sales are also affected by a variety of factors, including market demand, insurance coverage, and drug pricing policies in various countries. In addition, generic drugs of Sparsentan have also been promoted in some markets. The ingredients of generic drugs are basically the same as those of the original drugs, and the prices are usually more reasonable.
In China, since the original drug of sparsentan has not yet been launched on the market, patients may need to go through some overseas drug purchase channels or seek advice and help from doctors when obtaining such drugs. For some patients who are in urgent need of medication, they may consider purchasing drugs from overseas through legal channels.
Reference materials:https://en.wikipedia.org/wiki/Sparsentan
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)